Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice.

Human atherosclerotic lesions overexpress the lysosomal cysteine protease cathepsin S (Cat S), one of the most potent mammalian elastases known. In contrast, atheromata have low levels of the endogenous Cat S inhibitor cystatin C compared with normal arteries, suggesting involvement of this protease in atherogenesis. The present study tested this hypothesis directly by crossing Cat S-deficient (CatS(-/-)) mice with LDL receptor-deficient (LDLR(-/-)) mice that develop atherosclerosis on a high-cholesterol diet. Compared with LDLR(-/-) mice, double-knockout mice (CatS(-/-)LDLR(-/-)) developed significantly less atherosclerosis, as indicated by plaque size (plaque area and intimal thickening) and stage of development. These mice also had markedly reduced content of intimal macrophages, lipids, smooth muscle cells, collagen, CD4(+) T lymphocytes, and levels of IFN-gamma. CatS(-/-)LDLR(-/-) monocytes showed impaired subendothelial basement membrane transmigration, and aortas from CatS(-/-)LDLR(-/-) mice had preserved elastic laminae. These findings establish a pivotal role for Cat S in atherogenesis.

[1]  Peter Libby,et al.  Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis , 2002, Circulation research.

[2]  K. Schäkel,et al.  The CD16+ (FcγRIII+) Subset of Human Monocytes Preferentially Becomes Migratory Dendritic Cells in a Model Tissue Setting , 2002, The Journal of experimental medicine.

[3]  G. Hansson.  Regulation of Immune Mechanisms in Atherosclerosis , 2001, Annals of the New York Academy of Sciences.

[4]  P. Libby,et al.  Inflammation and Atherothrombosis , 2001, Annals of the New York Academy of Sciences.

[5]  R. Locksley,et al.  Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S. , 2001, Immunity.

[6]  Steffen Jung,et al.  The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium. , 2001, The Journal of clinical investigation.

[7]  P. Libby,et al.  Drilling for oxygen: angiogenesis involves proteolysis of the extracellular matrix. , 2001, Circulation research.

[8]  K. Moulton.  ArePlaque angiogenesis and atherosclerosis , 2001 .

[9]  P. Libby,et al.  Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. , 2001, The Journal of clinical investigation.

[10]  M. Dake,et al.  Vascular endothelial growth factor enhances atherosclerotic plaque progression , 2001, Nature Medicine.

[11]  K. Moulton.  Plaque angiogenesis and atherosclerosis. , 2001, Current atherosclerosis reports.

[12]  Mark L. Benson,et al.  Isolation of vascular smooth muscle cells from a single murine aorta. , 2001, Methods in cell science : an official journal of the Society for In Vitro Biology.

[13]  H. Tschesche,et al.  Matrix Metalloproteinases Collagenase-2, Macrophage Elastase, Collagenase-3, and Membrane Type 1-Matrix Metalloproteinase Impair Clotting by Degradation of Fibrinogen and Factor XII* , 2000, The Journal of Biological Chemistry.

[14]  S. Weiss,et al.  Regulation of Elastinolytic Cysteine Proteinase Activity in Normal and Cathepsin K–Deficient Human Macrophages , 2000, The Journal of experimental medicine.

[15]  A M Zeiher,et al.  Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. , 2000, Circulation research.

[16]  P. Libby.  Changing concepts of atherogenesis , 2000, Journal of internal medicine.

[17]  Y. Yazaki,et al.  An in vitro coculture model of transmigrant monocytes and foam cell formation. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[18]  P. Libby,et al.  Cystatin C deficiency in human atherosclerosis and aortic aneurysms. , 1999, The Journal of clinical investigation.

[19]  P. Libby,et al.  CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells. , 1999, The American journal of pathology.

[20]  J. Caillaud,et al.  Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice. , 1999, Circulation.

[21]  P. Libby,et al.  Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[22]  P. Libby,et al.  Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. , 1999, Circulation.

[23]  M A Konerding,et al.  Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. , 1999, Circulation.

[24]  G. Dranoff,et al.  Cathepsin S required for normal MHC class II peptide loading and germinal center development. , 1999, Immunity.

[25]  A. Rudensky,et al.  Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. , 1999, Immunity.

[26]  T. Luther,et al.  Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. , 1998, Blood.

[27]  P. Carmeliet,et al.  Reduced transplant arteriosclerosis in plasminogen-deficient mice. , 1998, The Journal of clinical investigation.

[28]  É. Allaire,et al.  Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. , 1998, The Journal of clinical investigation.

[29]  P. Libby,et al.  Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. , 1998, The Journal of clinical investigation.

[30]  P. Libby,et al.  Reduction of atherosclerosis in mice by inhibition of CD40 signalling , 1998, Nature.

[31]  Dean Y. Li,et al.  Elastin is an essential determinant of arterial morphogenesis , 1998, Nature.

[32]  T. Kodama,et al.  Immunohistochemical evidence for a macrophage scavenger receptor in Mato cells and reactive microglia of ischemia and Alzheimer's disease. , 1998, Biochemical and biophysical research communications.

[33]  P. Carmeliet,et al.  Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation , 1997, Nature Genetics.

[34]  A. Mcnicol,et al.  Organisation of basement membrane components in the human adult and fetal pituitary gland and in pituitary adenomas , 1997, Virchows Archiv.

[35]  G. D. De Meyer,et al.  Mechanisms of Neointima Formation—Lessons from Experimental Models , 1997, Vascular medicine.

[36]  P. Carmeliet,et al.  Impaired arterial neointima formation in mice with disruption of the plasminogen gene. , 1997, The Journal of clinical investigation.

[37]  H. Chapman,et al.  Emerging roles for cysteine proteases in human biology. , 1997, Annual review of physiology.

[38]  S. Shapiro,et al.  Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  A. Daugherty,et al.  Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice. Decreasing density with disease progression. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[40]  R. Virmani,et al.  Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. , 1996, Circulation.

[41]  C. Rackley,et al.  Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis. , 1996, American heart journal.

[42]  S. E. Brodie.  New York, New York, USA , 1996 .

[43]  S. Young,et al.  Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[44]  S. Weiss,et al.  Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Isner,et al.  Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. , 1995, Circulation.

[46]  P. Libby,et al.  Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic Plaque , 1995, Journal of cardiovascular pharmacology.

[47]  P. Libby,et al.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. , 1994, The Journal of clinical investigation.

[48]  D K Burns,et al.  Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. , 1994, The Journal of clinical investigation.

[49]  R. Hammer,et al.  Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. , 1993, The Journal of clinical investigation.

[50]  M. Davies,et al.  Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. , 1993, British heart journal.

[51]  A. J. Valente,et al.  Mechanisms in intimal monocyte-macrophage recruitment. A special role for monocyte chemotactic protein-1. , 1992, Circulation.

[52]  R. Mason,et al.  The specificity and elastinolytic activities of bovine cathepsins S and H. , 1992, Archives of biochemistry and biophysics.

[53]  D. Rich,et al.  Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. , 1992, The Journal of biological chemistry.

[54]  A. Henney,et al.  Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[55]  P. Libby,et al.  Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[56]  R. Maciewicz,et al.  A comparison of four cathepsins (B, L, N and S) with collagenolytic activity from rabbit spleen. , 1988, The Biochemical journal.

[57]  S. Gordon,et al.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage , 1981, European journal of immunology.